article thumbnail

Teva Pharmaceuticals, collaborators team up to donate behavioral health meds to free clinics, pharmacies

Fierce Healthcare

Teva Pharmaceuticals, collaborators team up to donate behavioral health meds to free clinics, pharmacies agliadkovskaya Thu, 05/04/2023 - 14:30

article thumbnail

What is Canada’s response? FDA’s decision to allow Florida to import pharmaceuticals

Healthcare ECONOMIST

Last week, FDA authorized the State of Florida to import pharmaceuticals from Canada. The price of branded pharmaceuticals in Canada is nearly three times the cost of identical pharmaceuticals in the US , so this approach could save the US money. demand, and importing medicines from Canada would not significantly lower U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharmaceutical industry rips 'draconian' price negotiation provision

Fierce Healthcare

The Biden administration and federal regulators may be taking a victory lap following the unveiling of the Centers for Medicare & Medicaid Services’ (CMS') price negotiations list, but major pl | Critics of President Joe Biden's policies to rein in prices for 10 Medicare Part D drugs believe the policy is "draconian" and will (..)

article thumbnail

AstraZeneca Acquires Fusion Pharmaceuticals for $2B to Bolster Radioconjugate Pipeline

HIT Consultant

What You Should Know: AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs).

article thumbnail

The March on Pharmaceutical Patents?

Sheppard Health Law

Of particular note is a newly unveiled framework for deciding whether the Government may exercise “march-in” rights and take a pharmaceutical company’s drug patents developed with federal funds and share them with other companies.

article thumbnail

BenchSci Launches ‘Map’ of Biology Research Platform for Pharmaceutical Research

HIT Consultant

Two major pharmaceutical companies are currently beta testing it, putting them at the forefront of leveraging AI enterprise-wide to advance new medicines for patients most in need. It’s not simply the proprietary AI that’s revolutionary.

article thumbnail

European Union Pharmaceutical Package: A Summary

Healthcare ECONOMIST

Today I’m turning this post over to some of my FTI colleagues in Europe ( Antoine Mialhe , Katja Murray and Valeria Fagone among others) who helped summarize the Reform of the EU pharmaceutical legislation that the European Union (EU) adopted on April 26, 2023. A more detailed analysis is in the PDF link below.